Mehul Joshi is recorded as CFO at Pulmonx Corp (LUNG) since April 3, 2024. Pulmonx Corp reported in an 8-K filed October 27, 2025 that Mehul Joshi resigned as respective roles at the Company, effective October 27, 2025. Pulmonx Corp reported in an 8-K filed October 27, 2025 that Mehul Joshi was appointed Consultant, effective October 28, 2025. Pulmonx Corp reported in an 8-K filed October 27, 2025 that Mehul Joshi resigned as Chief Financial Officer, effective October 27, 2025. Equibles holds 4 filed executive changes naming Mehul Joshi; each is listed under recent activity with its source filing. The proxy statement of Pulmonx Corp reports total compensation of $1,983,761 for Mehul Joshi in fiscal 2025, including a base salary of $381,199. Disclosed compensation is on record for 3 fiscal years. Mehul Joshi has spoken on 6 earnings calls across 1 company, most recently for Pulmonx Corp on July 30, 2025. Pulmonx Corp is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Pulmonx Corp includes Glendon E. French (CEO and Board Member), Glendon French (CEO and Board Member), Steven S. Williamson (CEO and Board Member) and 4 others.
“Steve Williamson and Mehul Joshi have resigned from their respective roles at the Company to pursue other opportunities.”
Pulmonx Corp Form 8-K, filed October 27, 2025
· Read the filing
“Effective Date: October 28, 2025 This Consulting Agreement (the “Agreement”) is made as of the Effective Date set forth above by and between Pulmonx Corporation, a Delaware corporation (“Client”) and the consultant named on the signature page hereto (“Consultant”).”
Pulmonx Corp Form 8-K, filed October 27, 2025
· Read the filing
Mehul Joshi on recent calls
“Total worldwide revenue for the three months ended June 30, 2025, was $23.9 million, a fifteen percent increase from $20.8 million in the same period of the prior year, and an increase of thirteen percent on a constant currency basis.”
“Total worldwide revenue for the three months ended March 31st, 2025 was $22.5 million, a 20% increase from $18.9 million in the same period of the prior year and an increase of 21% on a constant currency basis.”
“Total worldwide revenues for the three months ended December 31, 2024 was $23.8 million, a 23% increase over the prior year period, and also an increase of 23% on a constant currency basis.”
“Total worldwide revenue for the three months ended September 30, 2024, was $20.4 million, a 15% increase over the prior year period and also an increase of 15% on a constant currency basis.”
“Total worldwide revenue for the 3 months ended June 30, 2024 was $20.8 million, a 21% increase over the prior year period and also an increase of 21% on a constant currency basis.”
